Study Evaluating Two Treatment Strategies for Rectal Cancer in Patients ≥75 Years Old

Study Evaluating Two Treatment Strategies for Rectal Cancer in Patients ≥75 Years Old is a phase 3, randomised interventional study registered as NCT07118800 by UNICANCER, with a registry enrolment figure of 160 participants, started 2026-07-24 and due to reach its primary completion in 2030-12-15. Interventions recorded: FOLFOX4s; Short Course Radiotherapy. Conditions listed: Locally Advanced Rectal Adenocarcinoma. Primary outcome: TME-free survival. Colorectal eligibility wording from the registry: "Histologically confirmed diagnosis of adenocarcinoma of the rectum". No results are recorded here; the registry entry is the source.